Elisabetta Torlone

Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH‐based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5‐nations trial

Roel P.L.M. Hoogma, Peter Hammond, Ramón Gomis et al. · Diabetic Medicine · 2005 · 253 citations · Full text

Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.

C. Lalli, M. Ciofetta, Paola Sindaco et al. · Diabetes Care · 1999 · 195 citations

Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime

Paolo Rossetti, Simone Pampanelli, Carmine G. Fanelli et al. · Diabetes Care · 2003 · 150 citations

Better long‐term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal‐time lispro insulin

Francesca Porcellati, Paolo Rossetti, Simone Pampanelli et al. · Diabetic Medicine · 2004 · 128 citations

Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM

Elisabetta Torlone, Carmine G. Fanelli, A. M. Rambotti et al. · Diabetologia · 1994 · 127 citations · Full text

Metabolic Syndrome, Diabetes Management, Medicine +8